Lung Adenocarcinoma

• CLINICAL_TRIALS trial_result · 2010-10-06
  Clinical Trial Update: Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma [Phase 2]

  A Phase II clinical trial of sunitinib in bronchioloalveolar carcinoma or never-smokers with lung adenocarcinoma has completed.

• CLINICAL_TRIALS research · 2010-05-27
  Clinical Trial Update: A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations [Phase 2]

  A Phase 2 randomized crossover trial in untreated EGFR-mutant stage IIIB/IV lung adenocarcinoma compares erlotinib with docetaxel/cisplatin.

• CLINICAL_TRIALS trial_result · 2010-03-04
  Clinical Trial Update: Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma [Phase 2]

  Phase 2 study of sorafenib in never-smokers with lung adenocarcinoma (formerly bronchioloalveolar carcinoma) has completed.

• CLINICAL_TRIALS trial_result · 2010-02-10
  Clinical Trial Update: Pemetrexed (ALIMTA) and Gefitinib (IRESSA®) in Never-Smoker and Adenocarcinoma Patients With Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy [Phase 3]

  Phase 3 clinical trial update evaluating the combination of pemetrexed (ALIMTA) and gefitinib (IRESSA) in never-smoker patients with adenoca…

• CLINICAL_TRIALS research · 2009-05-18
  Clinical Trial Update: Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung Adenocarcinoma [NA]

  This clinical trial update describes a study investigating EGFR mutation–guided second-line therapy for patients with advanced lung adenocar…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.